To examine for a possible relationship between osteoarthritis and cardiovascular disease.
Design
A systematic review and meta-analysis.
Methods
Published and unpublished literature from: MEDLINE, EMBASE, CINAHL, the Cochrane Library, OpenGrey and clinical trial registers. Search to 22 November 2014. Cohort, case-control, randomised and non-randomised controlled trial papers reporting the prevalence of cardiovascular disease in osteoarthritis were included.
Results
Fifteen studies with 32,278,744 individuals were eligible. Pooled prevalence for overall cardiovascular disease pathology in people with osteoarthritis was 38.4% (95% confidence interval (CI): 37.2% to 39.6%). Individuals with osteoarthritis were almost three times as likely to have heart failure (relative risk (RR): 2.80; 95% CI: 2.25 to 3.49) or ischaemic heart disease (RR: 1.78; 95% CI: 1.18 to 2.69) compared with matched non-osteoarthritis cohorts. No significant difference was detected between the two groups for the risk of experiencing myocardial infarction or stroke. There was a three-fold decrease in the risk of experiencing a transient ischaemic attack in the osteoarthritis cohort compared with the non-osteoarthritis group.
Conclusions
Prevalence of cardiovascular disease in patients with osteoarthritis is significant. There was an observed increased risk of incident heart failure and ischaemic heart disease in people with osteoarthritis compared with matched controls. However, the relationship between osteoarthritis and cardiovascular disease is not straightforward and there is a need to better understand the potential common pathways linking pathophysiological mechanisms.
OsgoodETrudeauJJEatonTA. Development of a bedside pain assessment kit for the classification of patients with osteoarthritis. Rheumatol Int2015; 35: 1005–1013.
2.
GelberAC. In the clinic. Osteoarthritis. Ann Intern Med2014; 161: ITC1–ITC16.
3.
VosTFlaxmanADNaghaviM. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet2012; 380: 2163–2196.
4.
TurkiewiczAPeterssonIFBjörkJ. Current and future impact of osteoarthritis on health care: A population-based study with projections to year 2032. Osteoarthritis Cartilage2014; 22: 1826–1832.
RyanCGMcDonoughSKirwanJP. An investigation of association between chronic musculoskeletal pain and cardiovascular disease in the Health Survey for England (2008). Eur J Pain2014; 18: 740–750.
7.
GoodsonNJSmithBHHockingLJ. Cardiovascular risk factors associated with the metabolic syndrome are more prevalent in people reporting chronic pain: Results from a cross-sectional general population study. Pain2013; 154: 1595–1602.
8.
KerkhoffACMoreiraLBFuchsFD. Association between hypertension and musculoskeletal complaints: A population-based study. J Hypertens2012; 30: 2112–2117.
9.
Bag-OzbekAGilesJT. Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: Is there a paradoxical relationship?Curr Allergy Asthma Rep2015; 15: 497–497.
10.
van der BurgLRBoonenAvan AmelsvoortLG. Effects of cardiovascular comorbidities on work participation in rheumatic diseases: A prospective cohort study among working individuals. Arthritis Care Res2014; 66: 157–163.
11.
HaIHLeeJKimMRKimH. The association between the history of cardiovascular diseases and chronic low back pain in South Koreans: A cross-sectional study. PLoS One2014; 9: e93671–e93671.
12.
ErbNPaceAVDouglasKM. Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol2004; 33: 293–299.
13.
ChappleCMNicholsonHBaxterGD. Patient characteristics that predict progression of knee osteoarthritis: A systematic review of prognostic studies. Arthritis Care Res2011; 63: 1115–1125.
14.
BeloJNBergerMYReijmanM. Prognostic factors of progression of osteoarthritis of the knee: A systematic review of observational studies. Arthritis Rheum2007; 57: 13–26.
15.
IannoneFLapadulaG. Obesity and inflammation-targets for OA therapy. Curr Drug Targets2010; 11: 586–598.
16.
Findlay DM. Cascular pathology and osteoarthritis. Rheumatology 207; 46: 1763–1768.
17.
HanCDYangIHLeeWS. Correlation between metabolic syndrome and knee osteoarthritis: Data from the Korean National Health and Nutrition Examination Survey (KNHANES). BMC Public Health2013; 13: 603–603.
18.
van RooyMJPretoriusE. Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events. Curr Med Chem2014; 21: 2121–2129.
19.
MoherDLiberatiATetzlaffJPRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol2009; 62: 1006–1012.
20.
AltmanRAlarcónGAppelrouthD. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum1991; 34: 505–514.
21.
CASP. Critical appraisal checklists. http://www.casp-uk.net/#!casp-tools-checklists/c18f8 (2014, accessed 5 November 2014).
22.
JonssonHHelgadottirGPAspelundT. Hand osteoarthritis in older women is associated with carotid and coronary atherosclerosis: The AGES Reykjavik study. Ann Rheum Dis2009; 68: 1696–1700.
23.
ReidJLMortonDJWingardDL. Obesity and other cardiovascular disease risk factors and their association with osteoarthritis in Southern California American Indians, 2002–2006. Ethn Dis2010; 20: 416–422.
24.
RahmanMMKopecJAAnisAH. Risk of cardiovascular disease in patients with osteoarthritis: A prospective longitudinal study. Arthritis Care Res2013; 65: 1951–1958.
25.
HoevenTAKavousiMClockaertsS. Association of atherosclerosis with presence and progression of osteoarthritis: The Rotterdam Study. Ann Rheum Dis2013; 72: 646–651.
26.
TsuboiMHasegawaYMatsuyamaY. Do musculoskeletal degenerative diseases affect mortality and cause of death after 10 years in Japan?J Bone Miner Metab2011; 29: 217–223.
27.
WalstonJMcburnieMANewmanA. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: Results from the Cardiovascular Health Study. Arch Intern Med2002; 162: 2333–2341.
28.
MeekILPicavetHSVonkemanHE. Increased cardiovascular risk factors in different rheumatic diseases compared with the general population. Rheumatology2013; 52: 210–216.
29.
NielenMMvan SijlAMPetersMJ. Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: A cross-sectional study in primary care. BMC Musculoskelet Disord2012; 13: 150–150.
30.
OngKLWuBJCheungBM. Arthritis: Its prevalence, risk factors, and association with cardiovascular diseases in the United States, 1999 to 2008. Ann Epidemiol2013; 23: 80–86.
31.
RahmanMMKopecJACibereJ. The relationship between osteoarthritis and cardiovascular disease in a population health survey: A cross-sectional study. BMJ Open2013; 3: 5–5.
32.
DahaghinSBierma-ZeinstraSMKoesBW. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis2007; 66: 916–920.
33.
HaugenIKRamachandranVSMisraD. Hand osteoarthritis in relation to mortality and incidence of cardiovascular disease: Data from the Framingham Heart Study. Ann Rheum Dis2015; 74: 74–81.
34.
InoueRIshibashiYTsudaE. Medical problems and risk factors of metabolic syndrome among radiographic knee osteoarthritis patients in the Japanese general population. J Orthop Sci2011; 16: 704–709.
35.
SinghGMillerJDHuseDM. Consequences of increased systolic blood pressure in patients with osteoarthritis and rheumatoid arthritis. J Rheumatol2003; 30: 714–719.
36.
MurrayCJVosTLozanoR. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: A systematic analysis for the global burden of disease study 2010. Lancet2012; 380: 2197–2223.
37.
EttingerWHDavisMANeuhausJM. Long-term physical functioning in persons with knee osteoarthritis from NHANES I: Effects of comorbid medical conditions. J Clin Epidemiol1994; 47: 809–815.
38.
EttingerWHFriedLPHarrisT. Self-reported causes of physical disability in older people: The cardiovascular health study. J Am Geriatr Soc1994; 4: 1035–1044.
39.
FriedLPBandee-RocheKKasperJD. Association of comorbidity with disability in older women: The women’s health and ageing study. J Clin Epidemiol1999; 52: 27–37.
40.
SchmidtM. Cardiovascular risks associated with non-aspirin non-steroidal anti-inflammatory drug use. Dan Med J2015; 62: pii: B4987–pii: B4987.
41.
ThompsonPDBuchnerDPinaIL. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation2003; 107: 3109–3116.
42.
StubbsBHurleyMSmithT. What are the factors that influence physical activity participation in adults with knee and hip osteoarthritis? A systematic review of physical activity correlates. Clin Rehabil2015; 29: 80–94.
43.
NaciHIoannidisJP. Comparative effectiveness of exercise and drug interventions on mortality outcomes: Metaepidemiological study. BMJ2013; 347: f5577–f5577.
44.
UthmanOAvan der WindtDAJordanJL. Exercise for lower limb osteoarthritis: Systematic review incorporating trial sequential analysis and network meta-analysis. BMJ2013; 347: f5555–f5555.
45.
Fifth Joint Task Force of the European Society of Cardiology, European Association of Echolcardiography, European Association of Percutaneous Cardiovascular Interventions, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol2012; 19: 585–667.
46.
CapewellSO’FlahertyM. Rapid mortality falls after risk-factor changes in populations. Lancet2011; 378: 752–753.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
